Indian rotavirus vaccine found effective during clinical trial

Rotovac costs fifty times less than brands sold by global pharma companies

India launches vaccine against Japanese encephalitis

Can the indigenously developed JENVAC curb spread of brain fever?

Between hype and hope on Zika

Bharat Biotech's patent claim on vaccines to fight Zika is riddled with holes and rivals abroad are surging ahead

Decision on emergency authorisation for SII, Bharat Biotech’s COVID-19 vaccines deferred

Both manufacturers have been asked for more data before a final decision can be reached  

COVID-19 Vaccine Watch: India tops number of COVID-19 vaccine doses arranged from manufacturers

However, in terms of the proportion of the population that can be vaccinated with these doses, Canada leads the charts

Bharat Biotech COVID-19 vaccine gets govt panel nod for emergency use: Experts express concern

Recommendation to drug controller for emergency approval to India’s indigenous product against COVID-19

DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered

CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections

Delaying the second COVID-19 vaccine dose: A medical expert answers key questions

The uncertainty is around how long the protective effect of the first dose will last without a second shot

Centre signs deal with Serum Institute for 11 million COVID-19 vaccine doses: Sources

Talks on with Bharat Biotech; no official statement from government or manufacturers yet

COVID-19 immunity: how long does it last?

In UK’s second wave, previously infected health workers were either completely protected from reinfection or were asymptomatic 

India readies for COVID-19 vaccination but vexed questions on the solution remain

The risks the country needs to prepare for, precautions it needs to take, the logistics required and, above all, the implications of it all for …

Covid-19 vaccination drive rolled out in Punjab and Himachal Pradesh, skepticism lingers

Some ASHA workers refused to get the jab on Saturday 

Bhopal Covaxin trial participants allege side-effects, irregularities

Bhopal-based rights group writes to PM and Union health minister, demanding that ongoing Covaxin trial be halted there

COVID-19 vaccination begins in Bihar; 30,000 health workers to be inoculated today

The vaccination will be staggered over three phases with health and frontline workers and people of 50 to get the shot first

Vaccine production in South Africa: how an industry in its infancy can be developed

Only if investment is increased, sustained, and backed by political commitment, will the country have sufficient vaccine production capacity

Norway deaths, social media rumours: Why healthcare workers in Bihar are staying away from vaccines

Nearly 40% healthcare workers scheduled for first 3 days give the jab a miss

Gujarat recipients gung-ho on COVID-19 vaccine

The state will vaccinate about 440,000 healthcare workers and 355,000 frontline workers in the first round

Covaxin effective against UK Strain: What does this mean in absence of efficacy data?

Being a whole-virus vaccine doesn’t give Bharat Biotech product any advantage at this stage, say experts

Bharat Biotech COVID-19 vaccine claimed to have 80.6% efficacy

'Shot well tolerated in participants; adverse events balanced between vaccine and placebo arms of the trial'    

COVID vaccines: How to make sense of reports on their effectiveness

Real-world trials come with some problems: The target of vaccination, what time it was rolled out and emerging variants

Vaccine Scarcity: Government projection of vaccine demand goes haywire

Not expecting second surge, Centre exported more than 60 million doses

Why experts are not happy with India’s COVID-19 vaccine procurement, pricing policy

India only COVID-19 vaccine producer that has shifted burden onto citizens to pay for vaccines by opening private markets for them, experts say

Where are the vaccines for UP’s May 1 COVID-19 vaccination drive

There is extreme shortage of COVID-19 vaccines in India’s largest state and its government is facing problems in procuring them

Bharat Biotech will begin clinical trials of Covaxin on 2-18 age group

The clinical trials will be conducted to evaluate Covaxin’s safety and efficacy on a population group left out of India’s current …

COVID-19: Can India vaccinate all adults in 4 months?